Back to results
TerminatedPhase 2Phase 3

Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy

NCT00247975

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Ottawa Heart Institute

Ottawa, Ontario, Canada

View on ClinicalTrials.gov